Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does INFLIXIMAB Cause Incorrect dose administered by device? 17 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Incorrect dose administered by device have been filed in association with INFLIXIMAB (Renflexis). This represents 0.0% of all adverse event reports for INFLIXIMAB.

17
Reports of Incorrect dose administered by device with INFLIXIMAB
0.0%
of all INFLIXIMAB reports
0
Deaths
2
Hospitalizations

How Dangerous Is Incorrect dose administered by device From INFLIXIMAB?

Of the 17 reports, 2 (11.8%) required hospitalization.

Is Incorrect dose administered by device Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for INFLIXIMAB. However, 17 reports have been filed with the FAERS database.

What Other Side Effects Does INFLIXIMAB Cause?

Off label use (34,801) Drug ineffective (33,738) Condition aggravated (16,616) Rheumatoid arthritis (16,251) Pain (15,061) Fatigue (13,473) Arthralgia (13,441) Infusion related reaction (12,946) Product use issue (12,752) Drug intolerance (11,173)

What Other Drugs Cause Incorrect dose administered by device?

EXENATIDE (3,332) EVOLOCUMAB (2,840) SOMATROPIN (2,486) ALBUTEROL (1,236) ETANERCEPT (1,032) SECUKINUMAB (996) ERENUMAB-AOOE (973) BUDESONIDE\FORMOTEROL (753) INSULIN GLARGINE (753) BUDESONIDE\FORMOTEROL\GLYCOPYRROLATE (674)

Which INFLIXIMAB Alternatives Have Lower Incorrect dose administered by device Risk?

INFLIXIMAB vs INFLIXIMAB-ABDA INFLIXIMAB vs INFLIXIMAB-AXXQ INFLIXIMAB vs INFLIXIMAB-DYYB INFLIXIMAB vs INFLIXIMAB-QBTX INFLIXIMAB vs INFLIXIMAB, RECOMBINANT

Related Pages

INFLIXIMAB Full Profile All Incorrect dose administered by device Reports All Drugs Causing Incorrect dose administered by device INFLIXIMAB Demographics